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Obstructive sleep apnea syndrome (OSAS) is one of the most complex disorders of sleep; it in-
volves several genetic factors that contribute to the phenotype. Serotonin (5-HT) regulates a variety 
of visceral and physiological functions, including sleep. Gene 5-HTR2A polymorphisms may change 
the transcription of several receptors in the serotoninergic system, thereby contributing to OSAS. 
Aim: To investigate the prevalence of T102C and -1438G/A polymorphisms in the 5-HTR2A gene 
of patients with and without OSAS .
Material and Method: A molecular study of 100 index-cases and 100 controls of both genders. DNA 
was extracted from blood leukocytes samples and the regions that enclose both polymorphisms 
were amplified with PCR-RFLP. 
Study design: A cross-sectional case study. 
Results: There was a significant prevalence of males in index cases compared to controls (p<0.0001). 
No significant genotypic differences between cases and controls were found in T102C polymorphisms 
(p=1.000).There were significant differences between the AA genotype of -1438G/A polymorphisms 
and patients with OSAS (OR:2.3; CI95%:1.20-4.38, p=0.01). 
Conclusion: Serotonergic mechanisms may be related to OSAS. There were no differences in the 
prevalence of T102C polymorphisms in patients with OSAS and the control group. There is evidence 
of an association between the -1438G /A polymorphism and OSAS.
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INTRODUCTION
The obstructive sleep apnea syndrome (OSAS) 
is a common disorder of sleep affecting from 2% to 4% 
of adult males. It may be characterized by recurring 
sleep-induced pharyngeal airway collapse resulting in 
hypoxemia and hypercapnia.1 Several genetic factors are 
probably involved, since there are also many phenotypic 
components.2-5
Changes in central nervous control of upper ai-
rway muscles are considered an important component 
of this syndrome.6 The genioglossus muscle is innervated 
by neurons that originate in the hypoglossal nucleus 
within the brainstem; contractions of this muscle during 
inspiration help ventilate the lungs and keep upper 
airways open during wakefulness and sleep.7,8 Groups 
of serotonergic and noradrenergic cells may generate 
parallel patterns by stimulating directly the motor cells of 
the hypoglossal nerve, thereby regulating these dilating 
muscles. Thus, activation of these cell groups increases 
the activity of the genioglossus muscle.7-9
It is evident that serotonin (5-hydroxytryptamine 
or 5-HT), a central nervous system neurotransmitter, is 
involved in regulating several visceral and physiologic 
functions such as sleep, appetite, thermoregulation, pain 
perception, hormone secretion, and sexual behavior. 
Changes in the serotonergic system have been implied in 
several human diseases such as depression, headaches, 
epilepsy, obsessive-compulsive behaviors, temporoman-
dibular dysfunction, and affective disorders.6-9
Serotonin also has a relevant role in upper airway 
patency, as it excites airway motor neurons and intrin-
sically excites the motor neurons in the brainstem. The 
activity of neurons that provide 5-HT to motor neurons 
declines with sleep; most of the functional studies have 
shown that 5-HT and serotonergic neurons exert a sig-
nificant excitatory effect on respiratory motor neurons in 
vivo and in vitro. The activity of these neurons is maximal 
during wakefulness, and minimal during REM sleep. The 
sleep-related behavior of 5-HT on motor neurons results 
in upper airway collapse and the ensuing respiratory 
obstruction.10,11
Serotonin operates by means of a large family of 
5-HT receptors; these include the 5-HT2 receptors that 
comprise three subtypes (5-HT2A, 5-HT2B, and 5-HT2C) 
that have a similar molecular structure, pharmacology, 
and transduction signal patterns. The 5-HT2A and 5-HT2C 
subtypes have an important role in keeping upper ai-
rways stable and maintaining normal breathing in obese 
subjects.12 One of the receptor subtypes for serotonin 
- 5-HT2A - is mostly excitatory for the motor neurons of 
the hypoglossal muscle; the 5-HT2C subtype is excitatory 
for neurons in several areas of the brain. Although few 
excitatory responses have been analyzed with selective 
agents for receptor subtypes, evidence suggests that in 
some cases 5-HT2A mediates the responses, while in 
others, 5-HT2C is involved.12
The genes in the family 5-HT2 receptors (named 
HTR2 genes) have two introns (for genes 5-HTR2A and 
5-HTR2B) or three (5-HTR2C gene) in the coding sequen-
ce, which are all coupled positively to phospholipase 
C, and which mobilize intracellular Ca2+.12 The 5-HTR2A 
gene is on chromosome 13 (13q14-q21); it has a relati-
vely high amino acid sequence, identical to 5-HTR2C, 
although lower compared to the 5-HTR2B gene. The 
5-HTR2C gene is located on chromosome X (Xq24).12
A functional promoting variant of the 5-HTR2A 
gene may differentially alter transcription, thereby 
changing the number of receptors. Polymorphisms in 
the 5-HTR2 gene are associated with several diseases, 
including the OSAS; it affects the serotonergic system, 
thereby contributing to airway collapse during sleep. 
The excitatory effects of the 5-HT2C receptor are small; 
although the 5-HTR2C gene polymorphism is functional, 
the effect of an active polymorphic allele may not be 
sufficient for this polymorphism to be associated with 
the apnea/hypopnea index (AHI) because this subtype 
of receptor is less dominant in the nucleus of the hypl-
glossus.13,14 Conversely, a 5-HTR2A gene polymorphism 
has recently been found in patients with OSAS: it is de-
fined by a T->C substitution in the nucleotide position 
1028, and a G->A substitution in position -1438 of the 
promoting region of the gene.9 
OBJETIVE
The purpose of this study was to investigate the 
prevalence of T102C and -1438G/A polymorphisms in 
the 5-HTR2A gene with the polymerase chain reaction/
restriction fragment length polymorphism (PCR/RFLP) 
test in a sample of patients with and without the OSAS.
MATERIAL AND METHOD
The institutional review board approved this study 
(Opinion no. 342/2006) based on the regulating norms 
for research on human beings - Resolution 196/96 of the 
Ministry of Health.
A cross-sectional cohort study was carried out from 
1 July 2008 to 30 June 2010 of 100 index cases with the 
OSAS. There were 73 male and 27 female subjects with 
ages ranging from 23 to 70 years. The control group 
comprised 100 patients (40 male and 60 female) aged 
from 17 to 70 years. A full medical history was taken to 
investigate the presence of agitated sleep, night apnea, 
daytime drowsiness, medication use, arterial hyperten-
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sion, and depression. A systemic and otorhinolaryngo-
logical physical examination was carried out to assess 
the body mass index (BMI), the neck diameter, neck 
tumors, craniofacial malformations, and the nasal and 
oral cavities. Subjects then underwent general and spe-
cific tests for OSAS - cephalometry, nasofibroscopy with 
the Müeller maneuver, and polysomnography.
The following inclusion criteria were applied:
a) meeting criteria A or B, plus C for the diagnosis 
of the syndrome.
A. excessive daytime drowsiness not explained 
by other factors;
B. two or more of the following findings not ex-
plained by other factors:
gasping during sleep;
recurring awakenings from sleep; 
restless sleep, daytime fatigue;
poor concentration.
C. nighttime monitoring demonstrating more than 
five episodes of respiratory obstruction per hour during 
sleep. These events may include any combination of 
obstructive apnea/hypopnea or respiratory efforts with 
awakening.
b) absence of other somatic or laboratory findings 
in the general physical examination and tests;
c) absence of craniofacial dimorphism or tempo-
romandibular conditions, as seen in the specific physical 
examination;
d) absence of drug dependency, alcoholism, 
depression, or dementia, as investigated in the clinical 
history and psychiatric assessments;
e) absence of apparent genetic syndromes, as 
investigated by the clinical/genetic physical examination;
f) presence or absence of other cases in the family;
g) maximum age - 70 years.
h) BMI ≤ 35.
Exclusion criteria:
a) Patients aged over 70 years, as the prevalence 
of central sleep apnea increases with age;
b) presence of psychiatric disorders;
c) altered laboratory tests, and findings on the 
general and specific physical examination;
d) not presenting the minimal criteria for diagno-
sing the syndrome;
e) BMI > 35.
Patients for the control group were selected based 
on the same criteria above for patients with the OSAS, 
except for the AHI/hour, which for this group was ≤ 5.
The following data were gathered: age at the mo-
ment polysomnography was done, the BMI, and the AHI 
from the recordings of the polysomnography equipment 
(Stellat System QC, Harmonie TM, Canada). Patients 
were allocated to the following age groups: adolescent 
(11 to 17 years), young adult (18 to 40 years), adult (41 
to 65 years), and elderly (> 65 years).15,16 Patients were 
grouped according to the following classification based 
on the AHI: mild obstructive sleep apnea hypopnea syn-
drome (OSAHS) - AHI = 5 to 15.9 events/hour), moderate 
OSAHS - AHI = 16 to 30 events/hour), severe OSAHS 
- AHI > 30 events/hour).17 Patients were also grouped 
according to the BMI based on the WHO classification: 
ideal weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/
m2), obesity grade I (30.0-34.9 kg/m2), and obesity grade 
II (35.0-39.9 kg/m2).18 A BMI ≤ 35 limit was established 
to avoid effects of higher obesity grades on the AHI.
Molecular study
A total blood sample (4.0 mL) was collected in a 
Vacutainer tube with anticoagulant (EDTA), after con-
sent was obtained from patients or caretakers. Genomic 
DNA was extracted from blood samples using the Illustra 
Blood GenomicPrep Mini Spin Kit (GE Healthcare)TM 
according to the manufacturer’s instructions.
Nuclear DNA fragments including the polymor-
phic region of the 5-HTR2A gene were amplified by the 
polymerase chain reaction (PCR) using the FideliTaqTM 
PCR MasterMix (2X) (GE Healthcare®) kit to detect both 
polymorphisms (T102C and -1438G/A). In this reaction 
two pairs of primers - synthetic oligonucleotides - were 
used; the oligonucleotide sequence in the primers and 
the PCR conditions were taken from the literature.8,9
A 342 pb fragment was amplified as product of the 
PCR for the T102C polymorphism; it was then submitted 
to the restriction analysis (restriction fragment length 
polymorphism or RFLP) using the MspI enzyme (New 
England Biolabs)TM for 2:30 h at 37°C.8 Digestion of the 
mutant homozygotic sample fragment (CC) for the T102C 
polymorphism (both mutant alleles) yields two fragments 
(217 pb and 125 pb) because of recognition of the Mspl 
enzyme restriction site by substitution of the T->C nitro-
genated bases in the position 102 of the 5-HTR2A gene. 
The heterozygote samples (TC) for this polymorphism, 
after enzyme digestion, yielded three fragments: 342 
pb (wild allele-T), 217, and 125 pb (mutant allele-C). 
Samples with no polymorphism, therefore normal ho-
mozygotes (TT), contain only a 342 pb fragment, as the 
enzyme site is not recognized.
Similarly, to detect the -1438G/A polymorphism, 
a 469 pb fragment was obtained following PCR; it was 
subjected to RFLP with the MspI enzyme (New England 
Biolabs)TM for 2:30 h at 37°C.9 Digestion of a frag-
ment from normal homozygotic samples (GG) for the 
-1438G/A polymorphism yields two fragments (243 pb 
and 226 pb) because of recognition of the Mspl enzyme 
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restriction site. The mutant homozygotic samples (AA) 
for this polymorphism contain a single 469 pb fragment, 
as the enzyme site is not recognized by substitution of 
the G->A nitrogenated bases in the position -1438 of the 
5-HTR2A gene; the heterozygotic samples (GA) contain 
three fragments: 469 pb (mutant allele-A), 243, and 226 
pb (wild allele-G).
The products of both reactions (PCR/RFLP) were 
analyzed using 2% agarose gel electrophoresis in a TBE 
1X buffer containing ethidium bromide at 0.5 mg/mL, 
under ultraviolet light, to confirm the success of the re-
action; the gel was photographically documented.
Statistics
Descriptive statistics was applied to establish nor-
malcy of results. Student’s t test (two-tailed) was applied 
for independent samples with a normal distribution; the 
Mann-Whitney test was used for samples with a non-
normal distribution. If applicable, the chi-square test was 
used for comparisons among variables, and the odds 
ratio (95% confidence interval). The significance level 
was 5%. The Hardy-Weinberg equilibrium analysis was 
made for the genotype distribution.
The statistical tests were done using the GraphPad 
InStat version 3.00 software (GraphPad Software Inc, San 
Diego California USA; www.graphpad.com).
RESULTS
Of 100 patients with apnea (index cases), 73 (73%) 
were male and 27 (27%) were female. The age ranged 
from 23 to 70 years in males (mean - 50.1 years; SD ± 
12.5) and 43 to 65 years in females (mean - years; SD 
± 6.0). The BMI ranged from 21.2 to 35 kg/m2 in males 
(mean - 29.5 kg/m2; SD ± 3.8), and 21 to 35 kg/m2 in 
females (mean - 28.6 kg/m2; SD ± 3.5). The AHI ranged 
from 5.8 to 115 in males (mean - 37.5; SD ± 26.3) 5.4 to 
79 in females (mean - 19.6; SD ± 19.3).
Of 100 patients in the control group, 40 (40%) 
were male and 60 (60%) were female. The age ranged 
from 17 to 66 years in males (mean - 46.1 years; SD ± 
12.3) and 21 to 70 years in females (mean - 43.6 years; 
SD ± 11.7). The BMI ranged from 20 to 34.6 kg/m2 in 
males (mean - 26.8 kg/m2; SD ± 3.9) and 20 to 35 kg/
m2 in females (mean - 27.1 kg/m2; SD ± 4.0). The AHI 
ranged from 0 to 4.9 in males (mean - 2.3; SD ± 1.5) and 
0 to 4.9 in females (mean - 1.6; SD ± 1.4).
Table 1 presents demographic data for the 100 
index cases and 100 controls; Table 2 presents these 
data as mans ± standard deviation.
Males predominated among index cases (73%) 
and females predominated in the control group (60%), 
which was significant (p<0.0001).
The group of patients with OSAS had a higher 
prevalence of overweight and obesity grade I in the 
BMI classification -82% of cases; in the control group, 
ideal weight and obesity grade I were more prevalent 
(73%). This difference between groups was significant 
(p=0.0081).
The highest age prevalence in both groups (index 
Table 1. Distribution of demographic data of index cases 
(n=100) compared to the control group (n=100).
Variables
Index-cases
n (%)
Controls
n (%)
p*
Gender    
Male 73 (73) 40 (40) <0.0001
Female 27 (27) 60 (60)  
BMI    
Ideal weight 13 (13) 32 (32)  
Overweight 44 (44) 41 (41) 0.0081
Obesity grade I 38 (38) 24 (24)  
Obesity grade II 05 (05) 03 (03)  
Age    
Adolescent 0 (0) 01 (01)  
Young adult 12 (12) 35 (35) 0.0007
Adult 80 (80) 61 (61)  
Elderly 08 (08) 03 (03)  
 
Data gathered during 
polysomnography n (%)
 
AHI
Normal -- 100 (100)  
Mild 40 (40) -- NA
Moderate 15 (15) --  
Severe 45 (45) --  
BMI - body mass index.
AHI - apnea/hypopnea index.
NA - Not analyzed.
*Chi-square test.
Table 2. Clinical and polysomnographic parameters of index 
cases compared to controls.
Parameters
Index-cases
(n=100)
Controls
(n=100)
p
BMI (grade) 29.3 ± 3.7 27.0 ± 3.9 p<0.0001*
Age (years) 50.6 ± 11.1 44.6 ± 12.0 p=0.0004+
AHI 32.6 ± 25.7 1.9 ± 1.5 p<0.0001+
Values are presented as the mean ± standard deviation.
BMI - body mass index.
AHI - apnea hypopnea index.
*Student’s t test (two-tailed) for independent samples.
+Mann-Whitney test.
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cases and controls) was in the young adult (92%) and 
adult 96% ranges. There were no adolescents among the 
index cases. The statistical analysis of this variable in 
index cases and controls showed that it was significant 
(p<0.0001).
Table 2 presents the mean BMI values, the age, 
and the AHI, which were significantly higher among 
the index cases compared to the mean values in the 
control group.
Tables 3 to 7 present the molecular results and 
the comparison among variables.
The T and C allele frequencies for the index cases 
were T=0.56 and C=0.44; among controls they were 
T=0.545 and C=0.455. This difference was not statistically 
significant (p=0.8406). The G and A allele frequencies 
for the index cases were G=0.345 and A=0.655; among 
controls they were G=0.455 and A=0.545. This difference 
was statistically significant (p=0.0321).
There was a statistical difference in genotypes of 
the -1438G/A polymorphism among index cases com-
pared to the control group (p=0.0177).
The genotype frequencies for the T102C polymor-
phism were not in Hardy-Weinberg equilibrium both 
among index cases (χ2=11.511; p=0.00069) and controls 
(χ2=15.309; p=0.00009). The genotype frequencies for 
the -1438G/A polymorphism were not in Hardy-Wein-
berg equilibrium both among index cases (χ2=12.229; 
p=0.00047) and controls (χ2=18.628; p=0.00002).
Table 4 presents as odds ratio the relation of 
genotypes in index cases and controls.
There was no statistical difference between geno-
types TT and TC among cases x controls; the same ap-
plied to the genotype CC, as both groups had the same 
frequency of these genotypes.
Although the frequency of genotypes GG and GA 
was high in both groups, the control group had a signifi-
cantly higher frequency compared to index cases. The 
frequency of the AA genotype was significantly higher 
among index cases compared to controls.
The prevalence of the -1438G/A polymorphism 
genotypes among male index cases was significant com-
pared to controls (p<0.0001).
There was a statistically significant association 
between -1438G/A polymorphism genotypes and a BMI 
from 25 to 35 kg/m2 among index cases compared to 
controls (p<0.0182).
There was no association between both polymor-
phisms and the severity of OSAS among index cases.
Table 3. Distribution of genotypes in index cases and controls 
for T102C and -1438G/A polymorphisms of the 5-HTR2A gene.
Genotype
Index-cases
n (%)
Controls
n (%)
p*
TT 23 (23) 20 (20) 0.8711
TC 66 (66) 69 (69)  
CC 11 (11) 11 (11)  
GG 4 (4) 10 (10) 0.0177
GA 61 (61) 71 (71)  
AA 35 (35) 19 (19)  
*Chi-square test.
Table 4. Genotype relation between index cases and controls 
for T102C and -1438G/A polymorphisms of the 5-HTR2A gene. 
Genótipo 
(Casos x Controles)
Odds
ratio
(OR)
IC 95% Chi-square p
TT and TC (89 x 89) 1.0 0.41-2.43 0.000 1.000
CC (11 x 11) 1.0 0.41-2.43   
GG and GA (65 
x 81)
0.44 0.23-0.83 5.71 0.0169
AA (35 x 19) 2.3 1.20-4.38   
CI - 95% confidence interval
Table 5. Gender distribution of index cases and controls relative to the genotypes for T102C and -1438G/A polymorphisms of 
the 5-HTR2A gene.
Genotype
Index-cases Controls
p*Male 
n (%)
Female
 n (%)
Male
 n (%)
Female 
n (%)
TT and TC 64 25 33 56 0,3387
CC 9 2 7 4
GG and GA 40 25 31 50 <0,0001
AA 33 2 9 10
*Chi-square test.
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cases in adult males; only 8% of cases were aged over 
65 years.
The T102C polymorphism appears to be unrelated 
with OSAS, as the control group had the same frequency 
as index cases for the TT/TC and CC genotypes; this 
finding concurs with other published results.8,9 Although 
the 5-HT2A receptor is mostly related with serotonin (5-
HT) excitation within the representative motor nucleus 
of upper airways, lack of common polymorphisms or 
epigenetic changes that alter messenger RNA levels for 
the 5-HTR2A gene may explain the absence of associa-
tion between the T102C polymorphism and OSAS in this 
population; it is also considered a silent polymorphism 
and was present in a similar proportion in the control 
group.8,9,13,14
The genotype AA was significantly higher in index 
cases, whereas the genotypes GG/GA were higher in 
controls, meaning that relative to the -1438G/A polymor-
phism, the genotype AA may be associated with OSAS 
in the study population; this finding concurs with other 
published results.8,9
There was a significant gender difference between 
index cases and controls in relation to the -1438G/A poly-
morphism genotypes, which was not the case with T102C 
polymorphism genotypes. The comparison of genotypes 
with gender was done because of a higher prevalence of 
OSAS in males, as shown in the literature.1,6,9,19
There was no correlation between the AHI (obtai-
ned during polysomnography) and the genotypes of both 
polymorphisms in index cases, which again concurs with 
the literature.8,9 This condition may suggest that other 
mechanisms besides 5-HTR2A gene polymorphisms may 
be involved in the pathophysiology of OSAS. It is evident 
that OSAS is a phenotype of several related or unrelated 
disorders, and that it results from a complex association 
between genes and environmental modifying factors.9 
This may explain the statistically significant absence of 
association between both polymorphisms and the poly-
somnographic findings in the present study.
Table 6. Distribution of the BMI (body mass index) of index cases and controls relative to the genotypes for T102C and -1438G/A 
polymorphisms of the 5-HTR2A gene.
Genotype
Index-cases n (%) Controls n (%)
p*20 ≤ BMI < 
25 Kg/m2 
25 ≤ BMI ≤ 
35 Kg/m2
20 ≤ BMI < 
25 Kg/m2 
25 ≤ BMI ≤ 
35 Kg/m2
TT and TC 12 (12) 77 (77) 27 (27) 62 (62) 0,7542
CC 1 (1) 10 (10) 5 (5) 6 (6)
GG and GA 6 (6) 59 (59) 24 (24) 57 (57) 0,0182
AA 7 (7) 28 (28) 8 (8) 11 (11)
*Chi-square test.
Table 7. Distribution of the AHI (apnea/hypopnea index) of 
index cases relative to the genotypes for T102C and -1438G/A 
polymorphisms of the 5-HTR2A gene.
Genotype
Index-cases n (%)
p*
5 ≤ AHI ≤ 30 AHI > 30
TT and TC 50 (50) 39 (39) 0,7238
CC 5 (5) 6 (6)
GG and GA 38 (38) 27 (27) 0,4608
AA 17 (17) 18 (18)
*Chi-square test.
DISCUSSION
The serotonergic system is an important compo-
nent of sleep and relaxation of airways during sleep. 
Thus, factors that affect this system may result in sleep 
and respiratory disorders. The 5-HT2A receptor is an es-
sential component of the serotonergic system; it is under 
genetic control. Gene polymorphisms that code for the 
receptor may alter the functional state and serotonergic 
activity.9,12 Thus, our study aimed to investigate the pre-
valence of T102C and -1438G/A polymorphisms of the 
5-HTR2A gene in patients with and without OSAS. Until 
this time there were no published Brazilian papers on 
this topic; only two studies in the literature had reported 
the frequency of these polymorphisms and their asso-
ciation with OSAS,8,9 which underlines the importance 
of the present study.
All subjects underwent polysomnography to ob-
tain the AHI, through which the diagnosis of OSAS could 
be made to compose the groups (OSAS and controls). 
This criterion was followed strictly so that no patient with 
only a clinical exclusion diagnosis of OSAS is included 
in the control group, as was done in other published 
studies.6,8,9
The OSAS is more frequent in men of all age 
groups, although the prevalence increases with age.1 As 
in the literature, we found a higher prevalence of index 
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Airway size variations are probably defined by 
genetic influences on bone structure, and tongue and 
tonsil size; there may also be other factors that are 
acquired because of obesity.13,20-22 Although 5-HTR2A 
gene polymorphisms may have an important role in the 
activity of pharyngeal dilating muscles, other factors 
such as cephalometric characteristics and soft tissue 
structures may be determinant for opening the airways 
during sleep.8,23,24 Absence of craniofacial dimorphism 
and temporomandibular alterations and a BMI ≤ 35 kg/
m2 were two of the inclusion criteria for this study. These 
criteria were applied strictly to exclude these variables 
- and others - which affect upper airway patency. Thus, 
when the BMI was compared with the genotypes of 
both polymorphisms in index cases and controls, the 
BMI from 25 to 35 kg/m2 was related significantly with 
the -1438G/A polymorphism genotypes in index cases; 
this result concurs with those of the literature,8,9,25 as it 
results from more cases in this BMI range rather than 
the effect of the polymorphism.
Therefore, the T102C polymorphism appears to be 
unrelated with OSAS in our sample, compared with the 
-1438G/A polymorphism. This in turn may be associated 
with OSAS in the study population, especially in males 
with a BMI from 25 to 35 kg/m2, since the prevalence 
was higher among patients presenting these variables.
Genetic studies are being carried out to clarify 
some of the complexities of sleep and to open new 
therapeutic approaches for treating sleep disorders.25-27 
Genes are probably les involved in changes of state (non-
REM->REM) that are seen electrophysiologically during 
the sleep cycle; rather, genes are certainly related with 
the circadian rhythm and sleep homeostasis.28 The most 
common sleep disorders result from the interaction of 
several genes and environmental factors. Understanding 
the impact of genetic factors will help elucidate the 
pathophysiology of sleep disorders, and may provide 
support for therapeutic approaches.25-27
CONCLUSION
Using molecular techniques (PCR/RFLP) we iden-
tified T102C and -1438G polymorphisms of the 5-HTR2A 
gene, thereby adding to the molecular investigation of 
the OSAS. Serotonergic mechanisms may be related with 
the OSAS. There were no differences in the prevalence 
of the T102C polymorphism among OSAS patients and 
controls. There is evidence that the -1438G/A polymor-
phism is associated with the OSAS.
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